Quality at Glenmark
At Glenmark, quality is of paramount importance and stringent checks go into every product we manufacture. Our principles of excellence and the emphasis to ensure a culture of uncompromising quality, has earned us a remarkable reputation with our customers and regulatory agencies around the globe. This is reflected in the multiple accolades and recognitions conferred on us over the years. We have 14 state-of-the-art manufacturing facilities that are inspected by various regulatory
bodies such as the US-FDA, MHRA UK, SUKUL-CZ, RU-GMP Russia, TGA Australia, WHO GMP, TPD Canada, MCC South Africa and ANVISA of Brazil. At Glenmark, we are relentless in stepping up our quality systems across our research and manufacturing facilities, ensuring that our products, processes and infrastructure – all measure up to international expectations.
Product quality and safety at Glenmark
We are committed to manufacturing and delivering high-quality products to patients across the globe. The presence of strong governance systems and
review mechanisms to ensure quality control enables us to maintain compliance with stringent regulatory requirements across our product portfolio.
Strengthening our Quality Management System (QMS)
Glenmark focuses on quality by design and we continue to leverage our innovation-centric strategy to achieve operational excellence. We have implemented a robust Quality Management System (QMS) that establishes quality standards and methods for all our business units. Our QMS adopts a compliance approach, which encompasses the entire product lifecycle, from development to commercialization. The QMS is updated regularly based on new regulations and evolving compliance requirements to guarantee that operations comply with Current Good Manufacturing Practices (cGMP) criteria across the globe. This in turn assures a consistent supply of quality and dependable products.
We have implemented Current Good Manufacturing Practices (cGMP) throughout our manufacturing facilities, Good Distribution Practices (GDP) across our distribution network, Good Warehousing Practices (GWP), and good
Pharmacovigilance Practices (GVP), to ensure efficient post-marketing surveillance and Good Documentation Practices (GDP), in order to establish transparency and traceability across our quality management systems. We have also implemented several proactive control mechanisms, such as a Continuous Improvement Process (QIP), to integrate multiple checks and balances throughout our value chain. A QIP system ensures error elimination and a methodical approach to product quality control.
We consistently collect regulatory intelligence to evaluate new recommendations issued by various regulatory organizations which propels our efforts to integrate industry best practices across our facilities and enhancement of our business processes.
